Natural killer cells require monocytic Gr-1⁺/CD11b⁺ myeloid cells to eradicate orthotopically engrafted glioma cells

Gregory J. BakerDepartment of Neurosurgery, University of Michigan Medical School, Ann Arbor, MI, USA;Department of Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, MI, USA

Peter ChockleyGraduate Program in Immunology, University of Michigan Medical School, Ann Arbor, MI, USA

Daniel ZamlerDepartment of Neurosurgery, University of Michigan Medical School, Ann Arbor, MI, USA;Department of Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, MI, USA

Maria G. CastroDepartment of Neurosurgery, University of Michigan Medical School, Ann Arbor, MI, USA;Department of Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, MI, USA

Pedro R. LowensteinDepartment of Neurosurgery, University of Michigan Medical School, Ann Arbor, MI, USA;Department of Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, MI, USACorrespondence[email protected]

Natural killer cells require monocytic Gr-1⁺/CD11b⁺ myeloid cells to eradicate orthotopically engrafted glioma cells

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Natural killer cells require monocytic Gr-1+/CD11b+ myeloid cells to eradicate orthotopically engrafted glioma cells

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Natural killer cells require monocytic Gr-1⁺/CD11b⁺ myeloid cells to eradicate orthotopically engrafted glioma cells